So there will likely be a sell down until the 44.92 support level comes into play. Buy back will mean we could see a protracted underperformance until either a positive announcement or next earnings release. CVS has underperformed peers, sector and S&P most of the month. Be patient. Day traders will prosper on this quagmire performance.